Hyperliquid has experienced a significant increase in trading volume attributed to real-world assets, rising from about 2% in January 2026 to nearly 50% by mid-year. This surge reflects growing investor interest in tokenized real-world assets on the platform, potentially driving the creation of specialized blockchains. Market sentiment appears positive, though some uncertainty remains about Hyperliquid reaching $100 by the end of 2026. Investors should watch for new partnerships, technological advances, and regulatory changes that could impact trading volumes and market dynamics.
Hyperliquid's surge in real-world asset trading volume provides context for market activity. For readers following cryptocurrency markets, here is Pluang's snapshot as of Sep 18, 2026 00:22 WIB: out of 50 major cryptocurrencies, 47 rose and 2 fell today. Notable movers include CRV (Curve DAO Token) with a 1-day change of +11.74% and Pluang order activity of 28% Sell / 72% Buy, AAVE (Aave) up +11.70% with 14% Sell / 86% Buy, and BAL (Balancer) rising +11.14%.
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...
Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...
